SCHEMBL3964622

SCHEMBL3964622

C[C@H]1CN(CCCNc2ncc(Cl)c(-c3cc4c(C(=O)NC5CC5)cccc4s3)n2)CCN1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 6/20 0.40
AXL P30530 3/20 0.40
EGFR P00533 3/20 0.40
FGFR2 P21802 2/20 0.40
FGFR4 P22455 2/20 0.40
FGFR3 P22607 2/20 0.40
TYRO3 Q06418 13/20 0.38
FLT3 P36888 10/20 0.38
MERTK Q12866 10/20 0.38
GAS6 Q14393 8/20 0.38
SELP P16109 2/20 0.36
CHEK1 O14757 1/20 0.36
IKBKB O14920 1/20 0.36
AURKA O14965 1/20 0.36
PAK4 O96013 1/20 0.36
CHEK2 O96017 1/20 0.36
ABL1 P00519 1/20 0.36
INSR P06213 1/20 0.36
LCK P06239 1/20 0.36
CSNK2A2 P19784 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3958625 0.93 FGFR1 (0.38) FGFR1EGFRFGFR2FGFR4FGFR3
SCHEMBL3966411 0.92 TYRO3 (0.39) FGFR1AXLEGFRFGFR2FGFR4
Hydrochloric Acid SCHEMBL3965773 0.92 FGFR1 (0.39) FGFR1AXLEGFRFGFR2FGFR4
SCHEMBL3961602 0.91 FGFR1 (0.42) FGFR1AXLEGFRFGFR2FGFR4
Hydrochloric Acid SCHEMBL3969445 0.90 FGFR1 (0.42) FGFR1AXLEGFRFGFR2FGFR4
Hydrochloric Acid SCHEMBL3964263 0.90 FGFR1 (0.42) FGFR1AXLEGFRFGFR2FGFR4
SCHEMBL4073584 0.89 FGFR1 (0.49) FGFR1AXLEGFRFGFR2FGFR4
SCHEMBL3962136 0.89 FGFR1 (0.40) FGFR1AXLEGFRFGFR2FGFR4
Hydrochloric Acid SCHEMBL4084184 0.89 FGFR1 (0.49) FGFR1AXLEGFRFGFR2FGFR4
Hydrochloric Acid SCHEMBL3961798 0.89 FGFR1 (0.49) FGFR1AXLEGFRFGFR2FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989200-B1 [4-(BENZO[B]THIOPHEN-2-YL)-PYRIMIDIN-2-YL]-AMINE DERIVATIVES AS IKK-BETA INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES LILLY CO ELI (US) 2009-07-29 EP disclosed